Analogs and derivatives of rapamycin are provided, wherein the analogs and derivatives can bind to FK-506 binding protein (FKBP), or inhibit the mTOR function of an FKBP, or both. The analogs and derivatives are rapamycin include the rapamycin skeleton substituted at the 42-hydroxyl group with certain specified chemically feasible groups. Methods of using the rapamycin analogs and derivatives in treatment of malconditions such as cancer, and methods of synthesizing the rapamycin analogs and derivatives, are provided.
本文提供了
雷帕霉素的类似物和衍
生物,其中这些类似物和衍
生物可以与FK-506结合蛋白(FKBP)结合,或抑制FKBP的mTOR功能,或两者兼备。这些
雷帕霉素的类似物和衍
生物包括在42-羟基基团上用某些特定的
化学可行基团替代的
雷帕霉素骨架。本文还提供了使用这些
雷帕霉素类似物和衍
生物治疗癌症等疾病的方法以及合成这些
雷帕霉素类似物和衍
生物的方法。